Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

COVID-19 Can Cause Cavernous Smooth Muscle Damage: Investigation of the Effects of COVID-19 on Cavernous Smooth Muscle by Corpus Cavernosum Electromyography

NCT04980508 is registered in ClinicalTrials.gov with Ankara Yildirim Beyazıt University as lead sponsor.

NCT NCT04980508
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04980508 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
COVID-19 Can Cause Cavernous Smooth Muscle Damage: Investigation of the Effects of COVID-19 on Cavernous Smooth Muscle by Corpus Cavernosum Electromyography
Lead sponsor
Ankara Yildirim Beyazıt University
Phase
Not applicable
Overall status
Completed
Start date
February 20, 2021
Completion date
May 30, 2021
Enrollment
29 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

covid19, erectile dysfunction due to diseases classified elsewhere